ICH M13A published [Design Issues]

posted by ElMaestro  – Denmark, 2024-07-31 16:14 (320 d 06:51 ago) – Posting: # 24114
Views: 3,902

Hi Zuzana,

the ICH document was written in a generic fashion, it does not take into consideration specific cases like yours. This fully justifies a deviation from the guidance. It is for that reason that I think EU regulators would suggest to dose as per SmPC and not as per ICH guidance if you ask for scientific advice. So that is what I would lean towards.

Gut feeling only.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
17 visitors (0 registered, 17 guests [including 12 identified bots]).
Forum time: 23:06 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5